11:31 AM EDT, 08/26/2024 (MT Newswires) -- Evolent Health ( EVH ) has developed standardized and formulaic pricing methods that will help the company "manage volatility going forward" as it also reportedly received takeover interest from several private equity firms, RBC Capital Markets said in a note Monday.

The company has a "series" of mechanisms for renegotiating pricing to offset the change in cost profile as it is planning to reprice its risk-bearing performance suite contracts to align with changes throughout its "Medicaid and MA health plan partners," analysts Sean Dodge and Thomas Kelliher said.

"While there are some nuances to the various negotiations, per mgmt, it really is just a matter of adjusting PMPM [per member per month] rates," the analysts wrote.

Evolent received takeover interest from private equity firms and healthcare services providers including KKR (KKR), TPG (TPG), Elevance Health ( ELV ) , and Clayton Dubilier & Rice, Reuters reported Thursday.

RBC said that the bidders involved in the takeover "make sense" as TPG was an early investor in Evolent, while Elevance and CD&R formed a partnership earlier in 2024.

The brokerage maintained its outperform rating and $42 price target on the company's stock.

Price: 32.56, Change: -0.41, Percent Change: -1.24